EPIRUBICIN INOVAMED
Country: Israel
Language: English
Source: Ministry of Health
Summary of Product characteristics
(SPC)
18-08-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
EPIRUBICIN HYDROCHLORIDE
Available from:
INOVAMED LTD
ATC code:
L01DB03
Pharmaceutical form:
SOLUTION FOR INJECTION
Composition:
EPIRUBICIN HYDROCHLORIDE 2 MG / 1 ML
Administration route:
I.V, INTRAVESICAL
Prescription type:
Required
Manufactured by:
GENEPHARM S.A., GREECE
Therapeutic group:
EPIRUBICIN
Therapeutic area:
EPIRUBICIN
Therapeutic indications:
For the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma high doses, ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. Intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection. I.V. administration for the treatment of advanced bladder carcinoma.
Authorization date:
2016-04-30
